nach oben

Erschienen in:

01.06.2012 | CME Zertifizierte Fortbildung

Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz- und Kreislauferkrankungen

Teil 2: Lebensstil und kardiovaskuläres Risiko

verfasst von: Prof. Dr. H. Gohlke, C. Albus, G. Bönner, H. Darius, S. Eckert, C. Gohlke-Bärwolf, D. Gysan, H. Hahmann, M. Halle, R. Hambrecht, P. Mathes, H.-G. Predel, G. Sauer †, C. von Schacky, G. Schuler, J. Siegrist, J. Thiery, D. Tschöpe, H. Völler, A. Wirth

Erschienen in: Die Kardiologie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Teil 2 dieser Empfehlungen befasst sich mit den Aspekten des Lebensstils, die eine besondere Bedeutung für die Prävention von kardiovaskulären Erkrankungen haben: Rauchen, körperliche Aktivität, Ernährung und das mit Ernährung und körperlicher Aktivität in engem Zusammenhang stehende Übergewicht. Hier liegt ein besonders großes Potenzial zur nichtmedikamentösen Verbesserung des Gesundheitszustands der Bevölkerung.

Anthonisen NR, Skeans MA, Wise RA et al (2005) The effects of a smoking cessation intervention on 14.5-year mortality. A randomized clinical trial. Ann Intern Med 142:233–239PubMed

Bartecchi CE, MacKenzie TD, Schrier RW (1994) The human costs of tobacco use. N Engl J Med 330:907–912PubMedCrossRef

Bartecchi C, Alsever RN, Nevin-Woods C et al (2006) Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation 114:1490–1496PubMedCrossRef

Ezzati M, Lopez AD, Rodgers A et al (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360PubMedCrossRef

Iestra JA, Kromhout D, Schouw YT van der et al (2005) Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients – a systematic review. Circulation 112:924–934PubMedCrossRef

Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291:1238–1245PubMedCrossRef

Yusuf S, Hawken S, Ôunpuu S et al; INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952PubMedCrossRef

Batra A (2011) Therapie der Tabakabhängigkeit. Dtsch Arztebl Int 108(33):555–564PubMed

John U, Hanke M (2002) Tobacco smoking- and alcohol drinking-attributable cancer mortality in Germany. Eur J Cancer Prev 11:11–17PubMedCrossRef

10.

Meinertz T, Heitzer T (2002) Primäre und sekundäre Prävention der koronaren Herzkrankheit: Rauchen. Z Kardiol 91(Suppl 2):3–11PubMedCrossRef

11.

Völzke H, Neuhauser H, Moebus S et al (2006) Rauchen: Regionale Unterschiede in Deutschland. Dtsch Arztebl 103(42):A2784–A2790

12.

Löwel H, Meisinger C, Heier M et al (2006) Herzinfarkt und koronare Sterblichkeit in Süddeutschland. Ergebnisse des bevölkerungsbasierten MONICA/KORA-Herzinfarktregisters 1991–1993 und 2001–2003. Dtsch Ärztebl 103:A616–A622

13.

Keil U, Liese AD, Hense HW et al (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984–1992. Eur Heart J 19:1197–1207PubMedCrossRef

14.

Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years‘ observations on male British doctors. BMJ 328:1519–1527PubMedCrossRef

15.

Gohlke H, Yusuf S (2007) Quantitating loss of life by smoking a single cigarette. Clin Res Cardiol 96:522–523PubMedCrossRef

16.

Prescott E, Hippe M, Schnohr P et al (1998) Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316:1043–1047PubMedCrossRef

17.

Njølstad I, Arnesen E, Lund-Larsen PG (1996) Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93:450–456PubMed

18.

Teo KK, Ounpuu S, Hawken S et al; INTERHEART Study Investigators (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368:647–658PubMedCrossRef

19.

Rothenbacher D, Vossen CY, Hahmann et al (2011) Validated smoking cessation and prognosis in patients with stable coronary heart disease. J Am Coll Cardiol 58:196–201PubMedCrossRef

20.

Mohiuddin SM, Mooss AN, Hunter CB et al (2007) Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 131:446–452PubMedCrossRef

21.

Arzneimittelkommission der deutschen Ärzteschaft (2010) Empfehlungen zur Therapie der Tabakabhängigkeit. Arzneiverordnungen in der Praxis, Bd. 37, Sonderheft 2

22.

Kahn R, Robertson RM, Smith R, Eddy D (2008) The impact of prevention on reducing the burden of cardiovascular disease. Circulation 118:576–585PubMedCrossRef

23.

Salize HJ, Merkel S, Reinhard I et al (2009) Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch Intern Med 169(3):230–235PubMedCrossRef

24.

Heidrich J, Wellmann J, Heuschmann PU et al (2007) Mortality and morbidity from coronary heart disease attributable to passive smoking. Eur Heart J 28(20):2498–2502PubMedCrossRef

25.

Wells AJ (1988) An estimate of adult mortality in the United States from passive smoking. Environ Int 14:249–265CrossRef

26.

Barnoya J, Glantz SA (2005) Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111:2684–2698PubMedCrossRef

27.

Heiss C, Amabile N, Lee AC et al (2008) Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 51:1760–1771PubMedCrossRef

28.

Pechacek TF, Babb S (2004) How acute and reversible are the cardiovascular risks of secondhand smoke? BMJ 328:980–983PubMedCrossRef

29.

Raupach T, Schäfer K, Konstantinides S, Andreas S (2006) Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 27:386–392PubMedCrossRef

30.

Kallio K, Jokinen E, Raitakari OT et al (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115:3205–3212PubMedCrossRef

31.

Lightwood JM, Glantz SA (2009) Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation 120(14):1373–1379PubMedCrossRef

32.

Sargent JD, Demidenko E, Malenka DJ et al (2012) Smoking restrictions and hospitalization for acute coronary events in Germany. Clin Res Cardiol 101:227–235PubMedCrossRef

33.

Lloyd-Jones DM, Hong Y, Labarthe D et al (2010) The American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation 121:586–613PubMedCrossRef

34.

Piepoli MF, Corra U, Benzer W et al (2010) Secondary prevention through cardiac rehabilitation:from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 17:1–17PubMedCrossRef

35.

Shiroma EJ, Lee IM (2010) Physical activity and cardiovascular health lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation 122:743–752PubMedCrossRef

36.

Myers J, Prakash M, Froelicher V et al (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801PubMedCrossRef

37.

Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC (1986) Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 314:605–613PubMedCrossRef

38.

Wen CP, Wai JPM, Tsai MK et al (2011) Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378:1244–1253PubMedCrossRef

39.

Sattelmair J, Pertman J, Ding EL et al (2011) Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 124:789–795PubMedCrossRef

40.

Löllgen H, Löllgen D (2012) Risikoreduktion kardiovaskulärer Erkrankungen durch körperliche Aktivität. Internist 53:20–29PubMedCrossRef

41.

Abbott RD, White LR, Ross GW et al (2004) Walking and dementia in physically capable elderly men. JAMA 292:1447–1453PubMedCrossRef

42.

Dunstan DW, Barr ELM, Healy GN et al (2010) Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation 121:384–391PubMedCrossRef

43.

Jakes RW, Day NE, Khaw KT et al (2003) Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr 57:1089–1096PubMedCrossRef

44.

Johnson JL, Slentz CA, Houmard JA et al (2007) Exercise training amount and intensity effects on metabolic syndrome (from studies of a targeted risk reduction intervention through defined exercise). Am J Cardiol 100:1759–1766PubMedCrossRef

45.

Kraus WE, Houmard JA, Duscha BD et al (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347:1483–1492PubMedCrossRef

46.

Metkus TS, Baughman KL, Thompson PD (2010) Exercise prescription and primary prevention of cardiovascular disease. Circulation 121:2601–2604PubMedCrossRef

47.

Fletcher GF, Balady GJ, Amsterdam EA et al (2001)Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104:1694–1740PubMedCrossRef

48.

Sisson SB, Camhi SM, Church TS et al (2009) Leisure time sedentary behavior, occupational/domestic physical activity, and metabolic syndrome in U.S. men and women. Metab Syndr Rel Disorders 7:529–536CrossRef

49.

Artinian NT, Fletcher GF, Mozaffarian D et al; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing (2010) Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 122:406–441PubMedCrossRef

50.

Kavey RE, Daniels SR, Lauer RM et al (2003) American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107:1562–1566PubMedCrossRef

51.

Andersen LB, Harro M, Sardinha LB et al (2006) Physical activity and clustered cardiovascular risk in children: a cross-sectional study (the European Youth Heart Study). Lancet 368:299–304PubMedCrossRef

52.

Walther C, Gaede L, Adams V et al (2009). Effect of increased exercise in school children on physical fitness and endothelial progenitor cells: a prospective randomized trial. Circulation 120:2251–2259PubMedCrossRef

53.

O’Connor CM, Whellan DJ, Lee KL et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14):1439–1450CrossRef

54.

Hambrecht R, Walther C, Möbius-Winkler S et al (2004) Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 109:1371–1378PubMedCrossRef

55.

Munk PS, Staal EM, Butt N et al (2009) High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation. A randomized controlled trial evaluating the relationship to endothelial function and inflammation. Am Heart J 158(5):734–741PubMedCrossRef

56.

Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L (2011) Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 58:950–958PubMedCrossRef

57.

Corrado D, Pelliccia A, Heidbuchel H et al (2010) Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 31:243–259PubMedCrossRef

58.

Bjarnason-Wehrens B, Rauch B, Halle M (Hrsg) (2009) Leitlinie körperliche Aktivität zur Sekundärprävention und Therapie kardiovaskulärer Erkrankungen. Clin Res Cardiol (Suppl 4):1–44

59.

Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med 357:370–379PubMedCrossRef

60.

Patrick H, Nicklas TA (2005) A review of family and social determinants of children’s eating patterns and diet quality. J Am Coll Nutr 24:83–92PubMed

61.

Mente A, Koning L de, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169(7):659–669PubMedCrossRef

62.

Mitrou PN, Kipnis V, Thiébaut AC et al (2007) Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Int Med 167:2461–2468CrossRef

63.

Djoussé L, Gaziano JM (2007) Breakfast cereals and risk of heart failure in the physicians‘ health study I. Arch Intern Med 167:2080–2085PubMedCrossRef

64.

Pereira MA, O’Reilly E, Augustsson K et al (2004) Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164:370–376PubMedCrossRef

65.

Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287:2414–2423PubMedCrossRef

66.

Micha R, Mozaffarian D (2009) Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 5:335–344PubMedCrossRef

67.

Hu FB, Stampfer MJ, Manson JE et al (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337:1491–1499PubMedCrossRef

68.

Howard BV, Van Horn L, Hsia J et al (2006) Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295:655–666PubMedCrossRef

69.

Lichtenstein AH, Appel LJ, Brands M et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82–96PubMedCrossRef

70.

Harris WS, Mozaffarian D, Rimm E et al (2009) Omega-6 fatty acids and risk for cardiovascular disease a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119:902–907PubMedCrossRef

71.

Mozaffarian D, Psaty BM, Rimm EB et al (2004) Fish intake and risk of incident atrial fibrillation. Circulation 110:368–373PubMedCrossRef

72.

Mozaffarian MD, Rimm EB, Herrington DM (2004) Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutrition 80:1175–1184

73.

Nicholls SJ, Lundman P, Harmer JA et al (2006) Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. JACC 48:715–720PubMed

74.

Bendsen NT, Christensen R, Bartels EM, Astrup A (2011) Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 65:773–783PubMedCrossRef

75.

Sun Q, Ma J, Campos H et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115:1858–1865PubMedCrossRef

76.

Mozaffarian D, Katan MB, Ascherio A et al (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601–1613PubMedCrossRef

77.

Mozaffarian D, Clarke R (2009) Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63(Suppl 2):S22–S33PubMedCrossRef

78.

Okie S (2007) New York to trans fats: you’re out! N Engl J Med 356:2017–2021PubMedCrossRef

79.

Hulshof KF, Erp-Baart MA van, Anttolainen M et al (1999) Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 53:143–157PubMedCrossRef

80.

Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757PubMedCrossRef

81.

Wang C, Harris WS, Chung M et al (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84:5–17PubMed

82.

León H, Shibata MC, Sivakumaran S et al (2008) Effect of fish oil on arrhythmias and mortality: systematic review. Br Med J 337:a2931 (doi: 10.1136/bmj.a2931)CrossRef

83.

Rauch B, Schiele R, Schneider S et al (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122:2152–2159PubMedCrossRef

84.

Mozaffarian D, Ascherio A, Hu FB et al (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111:157–164PubMedCrossRef

85.

Smith SC Jr, Benjamin EJ, Bonow RO et al (2011) AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124(22):2458–2473PubMedCrossRef

86.

Hu FB, Stampfer MJ, Rimm EB et al (1999) A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281:1387–1394PubMedCrossRef

87.

Zazpe I, Beunza JJ, Bes-Rastrollo M et al (2011) Egg consumption and risk of cardiovascular disease in the SUN Project. Eur J Clin Nutr 65:676–682PubMedCrossRef

88.

Jenkins DJA, Jones PJ, Lamarche B et al (2011) Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA 306(8):831–839PubMedCrossRef

89.

Aune D, Chan DSM, Lau R et al (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343:d6617PubMedCrossRef

90.

Kris-Etherton PM, Lichtenstein AH, Howard BV et al; Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (2004) Antioxidant vitamin supplements and cardiovascular disease. Circulation 110:637–641PubMedCrossRef

91.

Lee IM, Cook NR, Gaziano JM et al (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA 294:56–65PubMedCrossRef

92.

Morris CD, Carson S (2003) Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Int Med 139:56–70PubMed

93.

Lorgeril M de, Salen P, Martin JL et al (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 106:1465–1469PubMedCrossRef

94.

Gaziano JM, Gaziano TA, Glynn RJ et al (2000) Light-to-moderate alcohol consumption and mortality in the Physicians‘ Health Study enrollment cohort. J Am Coll Cardiol 35:96–105PubMedCrossRef

95.

Janszky RL, Ljung R, Ahnve S et al (2008) Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study. Eur Heart J 29:45–53PubMedCrossRef

96.

Kloner RA, Rezkalla SH (2007) To drink or not to drink? That is the question. Circulation 116:1306–1317PubMedCrossRef

97.

Magnus P, Bakke E, Hoff DA et al (2011) Controlling for high-density lipoprotein cholesterol does not affect the magnitude of the relationship between alcohol and coronary heart disease/clinical perspective. Circulation 124:2296–2302PubMedCrossRef

98.

Mukamal KJ, Jensen MK, MSc Grønbæk M et al (2005) Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 112:1406–1413PubMedCrossRef

99.

Mukamal KJ, Chiuve SE, Rimm EB (2006) Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 166:2145–2150PubMedCrossRef

100.

Costanzo S, Di Castelnuovo A, Donati MB et al (2011) Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol 26(11):833–850PubMedCrossRef

101.

O’Keefe JH, Bybee KA, Lavie CJ (2007) Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 50:1009–1014CrossRef

102.

Brien SE, Ronksley PE, Turner BJ et al (2011) Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies BMJ 342:d636

103.

Lorgeril M de, Salen P, Martin JL et al (1999) Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779–785PubMed

104.

Singer MV, Teyssen S (2002) Serie - Alkoholismus: Moderater Alkoholkonsum - Gesundheitsförderlich oder schädlich? Dtsch Arztebl 99(16):A1103–1106

105.

Singer MV, Teyssen S (2001) Serie - Alkoholismus: Alkoholassoziierte Organschäden. Dtsch Arztebl 98(33):A2109–A2120

106.

He FJ, MacGregor GA (2002) Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 16:761–770PubMedCrossRef

107.

Sacks FM, Svetkey LP, Vollmer WM et al; DASH-Sodium Collaborative Research Group (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344:3–10PubMedCrossRef

108.

Bibbins-Domingo K, Chertow GM, Coxson PG et al (2010) Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 362:590–599PubMedCrossRef

109.

Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348:2599–2608PubMedCrossRef

110.

Trichopoulou A (2005) Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. Br Med J 330:991–997CrossRef

111.

Fung TT, McCullough ML, Newby PK et al (2005) Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 82(1):163–173PubMed

112.

Fung TT, Rexrode KM, Mantzoros CS et al (2009) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119:1093–1100PubMedCrossRef

113.

Kastorini C-M, Milionis HJ, Esposito K et al (2011) The effect of Mediterranean diet on metabolic syndrome and its components a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57:1299–313PubMedCrossRef

114.

Yusuf S, Hawken S, Ôunpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937PubMedCrossRef

115.

He M, Dam RM van, Rimm E et al (2010) Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation 121:2162–2168PubMedCrossRef

116.

Dai J, Miller AH, Bremner JD et al (2008) Adherence to the mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: a twin study. Circulation 117:169–175PubMedCrossRef

117.

Estruch R, Martinez-Gonzalez, Corella D et al; PREDIMED Study Investigators (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145:1–11PubMed

118.

Fitó M, Guxens M, Corella D et al (2007) Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med 167:1195–1203PubMedCrossRef

119.

Hanefeld M, Metzler W, Köhler C et al (2006) Das metabolische Syndrom: „common soil“ für Diabetes und Atherosklerose. Neue Möglichkeiten für eine integrierte Therapie. Herz 31:246–254PubMedCrossRef

120.

National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6(Suppl 2):51S–209S

121.

Berrington de Gonzalez AP, Hartge JR, Cerhan et al (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211–2219CrossRef

122.

Pischon T, Boeing H, Koffmann K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105–2120PubMedCrossRef

123.

Hauner H, Buchholz G, Hamann A et al (2007) Evidenzbasierte Leitlinie Prävention und Therapie der Adipositas für die Deutsche Adipositas-Gesellschaft, Deutsche Diabetes-Gesellschaft, Deutsche Gesellschaft für Ernährung, Deutsche Gesellschaft für Ernährungsmedizin. www.adipositas-gesellschaft.de (zugegriffen am 5.1.2012)

124.

Daniels SR, Arnett DK, Eckel RH et al (2005) Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 111:1999–2012PubMedCrossRef

125.

Giacchetti G, Faloia E, Mariniello B et al (2002) Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381–388PubMedCrossRef

126.

Bastard JP, Jardel C, Bruckert E et al (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338–3342PubMedCrossRef

127.

Yudkin JS, Stehouwer CD, Emeis JJ et al (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMedCrossRef

128.

Keaney JF, Larson MG, Vasan RS et al (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23:434–439PubMedCrossRef

129.

Seals DR, Gates PE (2005) Stiffening our resolve against adult weight gain. Hypertension 45:175–177PubMedCrossRef

130.

McGill HC Jr, McMahan CA, Hederick EE et al; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group (2002) Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712–2718PubMedCrossRef

131.

Hu FB, Willett WC, Li T et al (2004) Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 351:2694–2703PubMedCrossRef

132.

Murphy NF, MacIntyre K, Stewart S et al (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27:96–106PubMedCrossRef

133.

Deutsche Adipositas-Gesellschaft (DAG) Deutsche Gesellschaft für Psychosomatische Medizin und Psychotherapie, Deutsche Gesellschaft für Ernährungsmedizin (2010) S3-Leitlinie: Chirurgie der Adipositas. http://www.adipositas-gesellschaft.de (zugegriffen am 5.1.2012)

134.

Larsen TM, Dalskov SM, Baak M van et al (2010) Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 363:2102–2113PubMedCrossRef

135.

McMahan CA, Gidding SS, Fayad ZA et al (2005) Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 165:883–890PubMedCrossRef

136.

Mora S, Yanek LR, Moy TF et al (2005) Interaction of body mass index and framingham risk score in predicting incident coronary disease in families. Circulation 111:1871–1876PubMedCrossRef

137.

Peeters A, Barendregt JJ, Willekens F et al (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138:24–32PubMed

138.

Prospective Studies Collaboration; Whitlock G, Lewington S, Sherliker P et al (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analysis of 57 prospective studies. Lancet 373:1083–1096CrossRef

139.

Appel LJ, Clark JM, Yeh HC et al (2011) Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 365:1959–1968PubMedCrossRef

140.

Cornier MA, Marshall JA, Hill JO et al (2011) Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation 124:840–850PubMedCrossRef

141.

Goodpaster BH, DeLany JP, Otto AD et al (2010) Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304(16):1795–1802PubMedCrossRef

142.

Villareal DT, Chode S, Parimi N et al (2011) Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 364:1218–1229PubMedCrossRef

143.

Shai I, Schwarzfuchs D, Henkin Y et al (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359:229–241PubMedCrossRef

144.

Gögebakan O, Kohl A, Osterhoff MA et al (2011) Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the Diet, Obesity, and Genes (DiOGenes) study: a randomized controlled trial. Circulation 124:2829–2838PubMedCrossRef

145.

Sierra-Johnson J, Romera-Corral A, Somers VK (2008) Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 15:336–340PubMedCrossRef

146.

Jebb SA, Ahern AL, Olson AD et al (2011) Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 378:1485–1492PubMedCrossRef

147.

O’Brien PE, Sawyer SM, Laurie C et al (2010) Laparoscopic adjustable gastric banding in severely obese adolescents a randomized trial JAMA 303(6):519–526

148.

Rider OJ, Francis JM, Mohammed K et al (2009) Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 54:718–726PubMedCrossRef

149.

Adams TD, Gress RE, Smith SC et al (2007) Long-Term mortality after gastric bypass surgery. N Engl J Med 357:753–761PubMedCrossRef

150.

Borjesson M, Urhausen A, Kouidi E et al (2011) Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 18(3):446–458PubMedCrossRef

Titel: Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz- und Kreislauferkrankungen
Teil 2: Lebensstil und kardiovaskuläres Risiko
verfasst von: Prof. Dr. H. Gohlke
C. Albus
G. Bönner
H. Darius
S. Eckert
C. Gohlke-Bärwolf
D. Gysan
H. Hahmann
M. Halle
R. Hambrecht
P. Mathes
H.-G. Predel
G. Sauer †
C. von Schacky
G. Schuler
J. Siegrist
J. Thiery
D. Tschöpe
H. Völler
A. Wirth
Publikationsdatum: 01.06.2012
Verlag: Springer-Verlag
Erschienen in: Die Kardiologie / Ausgabe 3/2012
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI: https://doi.org/10.1007/s12181-012-0430-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Kann die Indikation zur Antikoagulation durch die Katheterablation von Vorhofflimmern ersetzt werden?

Update orale Plättchenhemmer

Therapie der hochgradigen Mitralklappeninsuffizienz

Vareniclin – Erhöhtes kardiovaskuläres Risiko bei der Raucherentwöhnung?

Interventionelle Behandlung der Aortenisthmusstenose im Erwachsenenalter